Volume 14 issue 3 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 14 issue 3

A Prognosis of Sustainability in the Pharmaceutical Industry

The pharmaceutical sector is a key player in the race for a more sustainable future, and pharmaceutical companies are endeavouring to reduce their carbon footprint, ...

10 October 2022 Volume 14 issue 3 disposal | emissions

Continue Reading →

Volume 14 issue 3

Why We Recognise HIV Vaccine Awareness Day

May 18th is dedicated to HIV Vaccine Awareness Day. The significance of this recurrence is embedded in the years of research that have been dedicated to finding a re...

10 October 2022 Volume 14 issue 3 AIDS | blood-borne viruses

Continue Reading →

Volume 14 issue 3

A Business Growth Tool: Patent Claiming Strategies

Developing a pharmaceutical product can take on the order of a decade from research (first inventing the drug) to development, and finally to FDA approval. While Pat...

10 October 2022 Volume 14 issue 3 developing | drug

Continue Reading →

Volume 14 issue 3

Under Pressure: Finding a More Sustainable Future for pMDIs

The transition away from the use of ozone-damaging chlorofluorocarbon (CFC) gases has been one of the major environmental achievements of modern times. Today, hindsi...

10 October 2022 Volume 14 issue 3 ability | absorption

Continue Reading →

Volume 14 issue 3

Use of High-field NMR in Covid-19 Drug Development

The Covid-19 NMR Consortium, an international collaboration of NMR experts, is conducting research to determine the ribonucleic acid (RNA) structure of SARS-CoV-2 an...

10 October 2022 Volume 14 issue 3 agent | conducting

Continue Reading →

Volume 14 issue 3

Virtual Screening in Modern Computational Chemistry

Virtual screening is a firmly established technique in computational drug design which has saved the pharmaceutical industry billions of dollars since its inception....

10 October 2022 Volume 14 issue 3 chemical | computational

Continue Reading →

Volume 14 issue 3

The Pharma Drug Discovery Industry Should Look Towards Manufacturing as the Blueprint for Automation

Within the manufacturing sector – whether it’s transported, FMCGs, electronics or building materials – a modern approach to automation is already in place. Holistic,...

10 October 2022 Volume 14 issue 3 automated | automation

Continue Reading →

Volume 14 issue 3

The Use of Predictive Analytics to Improve Quality in Clinical Trials Quality Assurance:

Independent or an Enabler – or Can it Be Both? The impact of poor quality in a clinical trial, often discovered late in the process, can not only add costs to add...

10 October 2022 Volume 14 issue 3 analytics | assessment

Continue Reading →

Volume 14 issue 3

The Transformational Potential of Prioritising Data Today

Covid has spurred regulators towards a more agile and innovation-supporting future, paving the way for new opportunities for all. If life sciences companies embrace ...

10 October 2022 Volume 14 issue 3 Affairs | agile

Continue Reading →

Volume 14 issue 3

New Technology and Automation in Labs: Data Risks and Privacy Compliance Issues

Within healthcare and life sciences, data science plays a major role in research and innovation. Improvements in computational speeds, storage capacity and connectiv...

10 October 2022 Volume 14 issue 3 AI | analytics

Continue Reading →